Schneider Lab

Our team focuses on precision medicine and disparities work in breast cancer research.

The Schneider Lab conducts translational cancer research at the Indiana University School of Medicine, under the direction of Dr. Bryan Schneider, MD. Dr. Schneider's research focuses on identifying genetic biomarkers to predict chemotherapy efficacy and the risk of chemotherapy induced side effects. Additionally, Dr. Schneider is the program founder of the Precision Genomics Clinic at IU Health, which uses a patient’s specific biological information to customize the course of treatment for each of individuals diagnosed with advanced forms of cancer. Dr. Schneider and the lab hope to make contributions in the development of cancer precision medicine.

02/25/2025

Dr. Schneider presents our group's work, which was recently incorporated into the cancer guidelines (nccn.org), at the NCCN congress at Northwestern University in Chicago.

Address

980 W Walnut Street
Indianapolis, IN
46202

Telephone

+13172744646

Website

http://medicine.iupui.edu/faculty-profile/bpschnei/Schneider-Bryan-Paul/

Alerts

Be the first to know and let us send you an email when Schneider Lab posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.